• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and

Giuseppe

Emeritus
[Source: Antimicrobial Agents Chemotherapy, full page: (LINK). Abstract, edited.]


Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility and therapeutic efficacy

Naoyuki Miyashita 1, Hiroto Akaike 2, Hideto Teranishi 2, Kazunobu Ouchi 2 and Niro Okimoto 1

Author Affiliations: <SUP>1</SUP>Department of Pediatrics <SUP>2</SUP>Department of Internal Medicine 1, Kawasaki Medical School, Okayama, Japan


ABSTRACT

We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (p = 0.0361 and p = 0.0237, respectively).


FOOTNOTES

Address correspondence to: Naoyuki Miyashita, MD, PhD, Department of Internal Medicine 1, Kawasaki Medical School, 2-1-80 Nakasange, Kita-ku, Okayama City, Okayama 700-8505, Japan, TEL: +81-86-225-2111 FAX: +81-86-232-8343, E-mail: nao@med.kawasaki-m.ac.jp

Copyright ? 2013, American Society for Microbiology. All Rights Reserved.


-
-------
 
Back
Top Bottom